WASHINGTON, Feb. 13 (TNSFR) -- Maridose LLC has submitted an application to the Drug Enforcement Administration seeking registration to manufacture Schedule I substances for research purposes. The company, based in Brunswick, Maine, intends to produce marijuana, marijuana extract, and tetrahydrocannabinols to supply DEA-registered researchers conducting approved studies. The application, filed on December 30, 2024, represents a step toward expanding the availability of federally regulated cannab . . .

Click here for more information about our products